Delivery Order SPE2DR25D3013-SPE2DR26F6U1A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,119.39 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml, a pharmaceutical product for medical supply needs. This firm fixed-price delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,836.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pens on October 30, 2025, with completion by October 31, 2025. This non-competitive delivery order represents a single pharmaceutical product transaction under AmerisourceBergen's existing contract vehicles with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to the federal medical supply chain and is...
- The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,008.80 for Emgality 120 mg/ml pen injectors on November 14, 2025, with completion expected by November 17, 2025. This firm fixed price, non-set-aside contract was awarded competitively and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader contracting relationship with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,255.50 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen/ml on December 19, 2025, with completion targeted for December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Emgality is a migraine prevention medication, reflecting the pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,105.72 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen/mL, a pharmaceutical product used in migraine treatment. This competitive award, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, carries firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a $2,008.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen medication, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract represents a pediatric delivery supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,273.90 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the contractor's headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, valued at $1,255.50, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement issued on December 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6U1ADelivery Order
The Defense Logistics Agency (DLA) awarded a $1,228.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen/milliliter on December 8, 2025, with an ultimate completion date of December 9, 2025. The award was made without set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen Drug Corp serves critical customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/7/25 |